MedPath

Celltrion Usa, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

FDA:14

Drug Approvals

STEQEYMA

Approval Date
Apr 21, 2025
FDA

Yuflyma

Approval Date
Jan 2, 2024
FDA

Adalimumab

Approval Date
Dec 8, 2023
FDA

Vegzelma

Approval Date
Feb 22, 2023
FDA

Abiraterone acetate

Approval Date
Oct 21, 2021
FDA

Clobazam

Approval Date
Feb 15, 2021
FDA

Zolmitriptan

Approval Date
Jun 5, 2020
FDA

Memantine Hydrochloride

Approval Date
Jun 5, 2020
FDA

Pregabalin

Approval Date
Mar 31, 2020
FDA

Fosaprepitant

Approval Date
Jan 20, 2020
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.